Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024
Journal of Antimicrobial Chemotherapy · 05.05.2026 · 81 (6)
DOI: 10.1093/jac/dkag155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 15.05.2026. Verfasst von K T Veldman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wageningen Bioveterinary Research, Wageningen University & Research, Houtribweg 39, Lelystad, the Netherlands. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamases, Escherichia coli Infections, Bacterial Proteins. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Agriculture, Fisheries, Food Security and Nature.
Abstract (Originalsprache)
Background
To minimize the risk of livestock becoming a reservoir of carbapenemase-producing Enterobacterales (CPE), it is prohibited to use carbapenems in food-producing animals in Europe. Nonetheless, CPE have been detected in several EU countries in pigs, poultry and cattle.
Objectives
To detect and characterize CPE from farm animals in the Netherlands obtained within the European monitoring programme for antimicrobial resistance in animals and food.
Methods
Caecal samples from livestock animals are screened for the presence of CPE according to the recommended EURL-AR protocol and supplementary molecular screening. WGS was used to further study the isolates and compare with human-derived CPE.
Results
In 2024, two CPE isolates were detected in caecal samples from a pig and a broiler. Both were Escherichia coli producing OXA-244 and showed reduced susceptibility to meropenem, imipenem and ertapenem. WGS confirmed the presence of blaOXA-244 gene on a chromosomally located IS-element. Although both isolates belonged to ST58 and were genetically similar, neither represented a clonal relationship with each other, nor with human-associated OXA-244-producing E. coli from national CPE surveillance. Follow-up investigations on both farms did not reveal additional CPE.
Conclusions
The finding of two OXA-244-producing E. coli isolates in livestock caecal samples demonstrates the added value of implementing a more sensitive screening method for detection of CPE with low-level resistance to carbapenems in the European AMR monitoring programme for animals and food.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wageningen Bioveterinary Research, Wageningen University & Research, Houtribweg 39, Lelystad, the Netherlands.
- Netherlands Food and Consumer Product Safety Authority (NVWA), Food Safety, Utrecht, The Netherlands.
- Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, Utrecht, the Netherlands.
- National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, The Netherlands.
- Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, Yalelaan 2, Utrecht, the Netherlands.
ORCID-Profile: A P A Hendrickx, M S M Brouwer
Förderung
- Ministry of Agriculture, Fisheries, Food Security and Nature
Zitieren
APA
Veldman, K. T., van Essen-Zandbergen, A., Geurts, Y., Harders, F., Wit, B., Stegeman, J. A., Hendrickx, A. P. A., & Brouwer, M. S. M. (2026). Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024. Journal of Antimicrobial Chemotherapy, 81(6). https://doi.org/10.1093/jac/dkag155
Vancouver
Veldman KT, van Essen-Zandbergen A, Geurts Y, Harders F, Wit B, Stegeman JA, et al. Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024. Journal of Antimicrobial Chemotherapy. 2026;81(6). doi:10.1093/jac/dkag155
BibTeX
@article{Veldman2026,
author = {Veldman, K T and van Essen-Zandbergen, A and Geurts, Y and Harders, F and Wit, B and Stegeman, J A and Hendrickx, A P A and Brouwer, M S M},
title = {Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/jac/dkag155}
}
EUVIMED